Chemical Compound

2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]ethanol (1:1); 2-Naphthoic acid, 4,4'-methylenebis[3-hydroxy-, hydroxyzine salt (6CI); Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, 4,4'-methylenebis[3-hydroxy-2-naphthalenecarboxylate] (1:1) (9CI); Atarax P; Equipose; Hydroxyzine pamoate; Hydroxyzyne pamoate; Masmoran; Paxisitil; Paxistil; Vistaril; Vistaril pamoate; 2-Naphthoic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 2-[2-[4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl]ethoxy]ethanol (1:1) (8CI); Ethanol, 2-[2-[4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl]ethoxy]-, 4,4'-methylenebis[3-hydroxy-2-naphthoate] (1:1) (salt) (8CI); 1-(p-Chloro-alpha-phenylbenzyl)-4-(2-hydroxyethoxyethyl)piperazine, pamoate

CAS Registry Number 10246-75-0
2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]ethanol (1:1); 2-Naphthoic acid, 4,4'-methylenebis[3-hydroxy-, hydroxyzine salt (6CI); Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, 4,4'-methylenebis[3-hydroxy-2-naphthalenecarboxylate] (1:1) (9CI); Atarax P; Equipose; Hydroxyzine pamoate; Hydroxyzyne pamoate; Masmoran; Paxisitil; Paxistil; Vistaril; Vistaril pamoate; 2-Naphthoic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 2-[2-[4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl]ethoxy]ethanol (1:1) (8CI); Ethanol, 2-[2-[4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl]ethoxy]-, 4,4'-methylenebis[3-hydroxy-2-naphthoate] (1:1) (salt) (8CI); 1-(p-Chloro-alpha-phenylbenzyl)-4-(2-hydroxyethoxyethyl)piperazine, pamoate 结构式
Primary record

2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]ethanol (1:1); 2-Naphthoic acid, 4,4'-methylenebis[3-hydroxy-, hydroxyzine salt (6CI); Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, 4,4'-methylenebis[3-hydroxy-2-naphthalenecarboxylate] (1:1) (9CI); Atarax P; Equipose; Hydroxyzine pamoate; Hydroxyzyne pamoate; Masmoran; Paxisitil; Paxistil; Vistaril; Vistaril pamoate; 2-Naphthoic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 2-[2-[4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl]ethoxy]ethanol (1:1) (8CI); Ethanol, 2-[2-[4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl]ethoxy]-, 4,4'-methylenebis[3-hydroxy-2-naphthoate] (1:1) (salt) (8CI); 1-(p-Chloro-alpha-phenylbenzyl)-4-(2-hydroxyethoxyethyl)piperazine, pamoate

库存
5,252 克
纯度
98.5 %
CAS
10246-75-0

化合物标识与属性

CAS
10246-75-0
PubChem CID
25096
SMILES
C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O
Canonical SMILES
O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O.OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1

名称与同义词

  • Hydroxyzine pamoate
  • Bobsule
  • Vistaril
  • Hydroxyzine embonate
  • Hydroxyzine (pamoate)
  • Paxisitil
  • Equipose
  • Masmoran
  • Paxistil
  • Vistaril Pamoate
  • Atarax P
  • 10246-75-0
  • Hydroxyzyne pamoate
  • Hy-Pam
  • Hydroxyzine pamoate salt
  • Pamoate, Hydroxyzine
  • hydroxyzinepamoate,usp
  • Atarax-P (TN)
  • Spectrum_000911
  • Vistaril pamoate (TN)
  • hy-pam ""25
  • RefChem:789579
  • Spectrum2_001000
  • Spectrum3_000463
  • Spectrum4_000013
  • Spectrum5_000838
  • M20215MUFR
  • UNII-M20215MUFR
  • C44H43ClN2O8
  • HYYDROXYZINE PAMOATE
  • 6-Ethylthiomorpholin-3-one
  • AC1L18EU
  • MLS000028605
  • Hydroxyzine pamoate [USP:JAN]
  • SCHEMBL41333
  • SCHEMBL41334
  • BSPBio_002166
  • KBioGR_000385
  • KBioSS_001391
  • Hydroxyzine pamoate [USAN:JAN]
  • DivK1c_000503
  • NSC-757063
  • SPECTRUM1500345
  • DTXSID00907580
  • EINECS 233-582-1
  • SPBio_001099
  • HY-PAM "25
  • orb1310988
  • CHEMBL1200467
  • HYDROXYZINE PAMOATE [MI]
  • SCHEMBL29359711
  • CHEBI:31680
  • CTK0H5141
  • ERK5-1L21
  • HMS501J05
  • HY-B0895R
  • HY-PAM "25"
  • KBio1_000503
  • KBio2_001391
  • KBio2_003959
  • KBio2_006527
  • KBio3_001386
  • HYDROXYZINE PAMOATE [JAN]
  • ASDOKGIIKXGMNB-UHFFFAOYSA-N
  • Hydroxyzine (pamoate) (Standard)
  • Hydroxyzine pamoate (JP18/USP)
  • MFCD00058051
  • NINDS_000503
  • DTXCID201336670
  • HMS1920F11
  • HMS2091L19
  • HMS2235O19
  • HMS3886G14
  • HMS5085C07
  • Pharmakon1600-01500345
  • C23H16O6.C21H27ClN2O2
  • HYDROXYZINE PAMOATE [VANDF]
  • CID25096
  • EBD55260
  • HY-B0895
  • CCG-40218
  • HYDROXYZINE EMBONATE [MART.]
  • HYDROXYZINE PAMOATE [USP-RS]
  • MSK179447
  • NSC757063
  • s5649
  • HYDROXYZINE EMBONATE [WHO-DD]
  • SMR000058728
  • AKOS015914218
  • C21H27ClN2O2.C23H16O6
  • CS-4358
  • NSC 757063
  • IDI1_000503
  • HYDROXYZINE PAMOATE [ORANGE BOOK]
  • NCGC00021152-02
  • NCGC00021152-03
  • NCGC00094698-01
  • NCGC00094698-02
  • DA-54190
  • FH171674
  • MS-31366
  • HYDROXYZINE PAMOATE [USP MONOGRAPH]
  • SBI-0051413.P003
  • LS-171818
  • FT-0697190
  • NS00087142
  • 10246-75-0, 68-88-2 [hydroxyzine]
  • D01096
  • F15112
  • C21-H27-Cl-N2-O2.C23-H16-O6
  • A991483
  • SR-01000003149
  • SR-01000003149-2
  • SR-01000003149-4
  • I14-44826
  • Q27114645
  • 2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1)
  • 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid; 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol
  • 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid;2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol
  • (+-)-2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1)
  • 1-(p-chloro-|A-phenylbenzyl)-4-(2-hydroxyethoxyethyl)piperazine, pamoate
  • 2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethan-1-ol 4,4'-methylenebis(3-hydroxy-2-naphthoate)
  • 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol
  • 2-naphthoic acid, 4,4'-methylenebis[3-hydroxy-, hydroxyzine salt (6ci)
  • 4-[(3-Carboxy-2-hydroxy-naphthalen-1-yl)methyl]-3-hydroxy-naphthalene-2-carboxylic acid; 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol
  • Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, (+-)-, compd. with 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic acid) (1:1)
  • Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, compd. with 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic acid) (1:1)
  • Hydroxyzine pamoate, United States Pharmacopeia (USP) Reference Standard
  • 4-[(3-carboxy-2-hydroxy-1-naphthyl)methyl]-3-hydroxy-naphthalene-2-carboxylic acid
  • (+/-)-2-(2-(4-(P-CHLORO-.ALPHA.-PHENYLBENZYL)-1-PIPERAZINYL)ETHOXY)ETHANOL 4,4'-METHYLENEBIS(3-HYDROXY-2-NAPHTHOATE) (1:1)
  • 2-(2-(4-((RS)-(4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethanol mono(4,4'-methylenebis(3-hydroxy-2-naphthoate))
  • 2-Naphthalenecarboxylic acid, 4,4'-methylenebis(3-hydroxy-, compd. with 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)ethanol (1:1)
  • 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]ethanol (1:1)
  • 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]ethanol (1:1); 2-Naphthoic acid, 4,4'-methylenebis[3-hydroxy-, hydroxyzine salt (6CI); Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, 4,4'-methylenebis[3-hydroxy-2-naphthalenecarboxylate] (1:1) (9CI); Atarax P; Equipose; Hydroxyzine pamoate; Hydroxyzyne pamoate; Masmoran; Paxisitil; Paxistil; Vistaril; Vistaril pamoate; 2-Naphthoic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 2-[2-[4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl]ethoxy]ethanol (1:1) (8CI); Ethanol, 2-[2-[4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl]ethoxy]-, 4,4'-methylenebis[3-hydroxy-2-naphthoate] (1:1) (salt) (8CI); 1-(p-Chloro-alpha-phenylbenzyl)-4-(2-hydroxyethoxyethyl)piperazine, pamoate
  • 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-,compound with 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]ethanol (1:1)
  • 2-Naphthoic acid, 4,4'-methylenebis[3-hydroxy-, compd. with 2-[2-[4-(p-chloro-.alpha.-phenylbenzyl)-1-piperazinyl]ethoxy]ethanol (1:1)
  • 233-582-1
  • 4,4'-Methylenebis(3-hydroxynaphthalene-2-carboxylic acid)--2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)ethan-1-ol (1/1)
  • 4-[(3-carboxy-2-hydroxy-1-naphthyl)methyl]-3-hydroxy-naphthalene-2-carboxylic acid; 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol
  • 4-[(3-carboxy-2-hydroxy-1-naphthyl)methyl]-3-hydroxy-naphthalene-2-carboxylic acid;2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol
  • ETHANOL, 2-(2-(4-((4-CHLOROPHENYL)PHENYLMETHYL)-1-PIPERAZINYL)ETHOXY)-, (+/-)-, COMPD. WITH 4,4'-METHYLENEBIS(3-HYDROXY-2-NAPHTHALENECARBOXYLIC ACID) (1:1)
  • Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, compound with 4,4'-Methylenebis(3-hydroxy-2-naphthalenecarboxylic Acid)(1:1)